Hepatitis Research Today is a free monthly online journal that collates and summarizes the latest research about Hepatitis, including details on hepatitis a, b, c, causes, symptoms.

Volume 2 (2007), Issue 10 (October)

1. Plasmacytoid dendritic cells initiate a complex chemokine and cytokine network and are a viable drug target in chronic HCV patients.
   J Exp Med, 204(10): 2423-37. [Abstract] [Full-text]
2. Serum concentrations of insulin-like growth factor-I (igf-I) as a marker of liver fibrosis in patients with chronic hepatitis C.
   Dig Dis Sci, 52(11): 3245-50. [Abstract] [Full-text]
3. High deferral rates and poorer treatment outcomes for HCV patients with psychiatric and substance use comorbidities.
   Dig Dis Sci, 52(11): 3251-8. [Abstract] [Full-text]
4. Potential role of RNAi in the treatment of HCV infection.
   Expert Rev Anti Infect Ther, 5(5): 823-31. [Abstract] [Full-text]
5. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy.
   Clin Infect Dis, 45(9): 1221-9. [Abstract] [Full-text]
6. Antiviral activity and hepatoprotection by heme oxygenase-1 in hepatitis B virus infection.
   Gastroenterology, 133(4): 1156-65. [Abstract] [Full-text]
7. Ultra-rapid cardiotoxicity of the hepatitis C virus protease inhibitor BILN 2061 in the urokinase-type plasminogen activator mouse.
   Gastroenterology, 133(4): 1144-55. [Abstract] [Full-text]
8. HCV-specific T-cell response in relation to viral kinetics and treatment outcome (DITTO-HCV project).
   Gastroenterology, 133(4): 1132-43. [Abstract] [Full-text]
9. The impact of hepatitis B viral load on recurrence after complete necrosis in patients with hepatocellular carcinoma who receive transarterial chemolipiodolization: implications for viral suppression to reduce the risk of cancer recurrence.
   Cancer, 110(8): 1760-7. [Abstract] [Full-text]
10. Serum immunoglobulin G antibodies to the GOR autoepitope are present in patients with occult hepatitis C virus (HCV) infection despite lack of HCV-specific antibodies.
    Clin Vaccine Immunol, 14(10): 1302-6. [Abstract] [Full-text]
11. Correlates of hepatitis B testing among Chinese Americans.
    J Community Health, 32(6): 379-90. [Abstract] [Full-text]
12. Retrospective study of the prevalence of human T-cell lymphotropic virus-type 1/2, HIV, and HBV in pregnant women in Argentina.
    J Med Virol, 79(12): 1974-8. [Abstract] [Full-text]
13. Hepatitis C virus does not infect muscle, the intervertebral disk, or the meniscus in patients with chronic hepatitis C.
    J Med Virol, 79(12): 1818-20. [Abstract] [Full-text]
14. Population-based study on the seroprevalence of hepatitis A, B, and C virus infection in Amsterdam, 2004.
    J Med Virol, 79(12): 1802-10. [Abstract] [Full-text]
15. Comparison of real-time fluorescent RT-PCR and conventional RT-PCR for the detection of hepatitis E virus genotypes prevalent in China.
    J Med Virol, 79(12): 1966-73. [Abstract] [Full-text]
16. Use of replacement blood donors to study the epidemiology of major blood-borne viruses in the general population of Maputo, Mozambique.
    J Med Virol, 79(12): 1832-40. [Abstract] [Full-text]
17. Successful treatment of an entecavir-resistant hepatitis B virus variant.
    J Med Virol, 79(12): 1811-7. [Abstract] [Full-text]
18. Seroprevalence of hepatitis B and C viruses among HIV-infected pregnant women in Uganda and Rwanda.
    J Med Virol, 79(12): 1797-801. [Abstract] [Full-text]
19. Treatment of hepatitis-associated aplastic anemia with high-dose cyclophosphamide.
    Pediatr Blood Cancer, 49(7): 947-51. [Abstract] [Full-text]
20. Hepatitis A vaccine versus immune globulin for postexposure prophylaxis.
    N Engl J Med, 357(17): 1685-94. [Abstract] [Full-text]
21. Analysis of the complete hepatitis B virus genome in patients with genotype C chronic hepatitis and hepatocellular carcinoma.
    Cancer Sci, 98(12): 1921-9. [Abstract] [Full-text]
22. T-regulatory lymphocytes and chronic viral hepatitis.
    Expert Opin Biol Ther, 7(11): 1689-703. [Abstract] [Full-text]
23. Antigen-induced regulatory T cells in HBV chronically infected patients.
    Virology, 368(1): 41-9. [Abstract] [Full-text]
24. Putative association of Fas and FasL gene polymorphisms with clinical outcomes of hepatitis B virus infection.
    Intervirology, 50(5): 369-76. [Abstract] [Full-text]
25. Influence of Kupffer cell inactivation on cycloheximide-induced hepatic injury.
    Toxicology, 241(3): 106-18. [Abstract] [Full-text]
26. Managing symptomatic drug-induced liver injury in HIV-hepatitis C virus-coinfected patients: a role for interferon.
    Clin Infect Dis, 45(10): 1386-92. [Abstract] [Full-text]

© 2006-2008 Hepatitis Research Today. All Rights Reserved.